Cytek Biosciences, Inc. (CTKB)
NASDAQ: CTKB · Real-Time Price · USD
3.920
-0.090 (-2.24%)
At close: Apr 1, 2025, 4:00 PM
3.914
-0.006 (-0.15%)
After-hours: Apr 1, 2025, 7:32 PM EDT

Cytek Biosciences Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2015
Cash & Equivalents
98.72167.3296.6364.62165.23
Upgrade
Short-Term Investments
179.1595.1144.55--
Upgrade
Cash & Short-Term Investments
277.86262.41341.15364.62165.23
Upgrade
Cash Growth
5.89%-23.08%-6.44%120.67%448.54%
Upgrade
Accounts Receivable
60.5955.9348.8629.7616.99
Upgrade
Other Receivables
-0.192.01-0.131.11
Upgrade
Receivables
60.5956.1250.8829.6318.1
Upgrade
Inventory
44.0161.1748.7832.5723.05
Upgrade
Prepaid Expenses
4.643.994.454.210.91
Upgrade
Restricted Cash
0.030.332.9-0.89
Upgrade
Other Current Assets
9.328.045.880.710.45
Upgrade
Total Current Assets
396.45392.06454.02431.73208.62
Upgrade
Property, Plant & Equipment
28.1329.2627.575.852.14
Upgrade
Long-Term Investments
1.6----
Upgrade
Goodwill
16.6616.1810.1410.140.48
Upgrade
Other Intangible Assets
20.1323.084.334.740.27
Upgrade
Long-Term Deferred Tax Assets
33.3730.4920.469.177.38
Upgrade
Other Long-Term Assets
3.163.392.961.671.09
Upgrade
Total Assets
499.5494.46519.48463.31219.98
Upgrade
Accounts Payable
5.533.034.813.032.94
Upgrade
Accrued Expenses
21.6918.9920.4214.898.65
Upgrade
Short-Term Debt
4.16---2.77
Upgrade
Current Portion of Long-Term Debt
0.50.570.58--
Upgrade
Current Portion of Leases
3.762.442.93--
Upgrade
Current Income Taxes Payable
1.521.30.252.480.47
Upgrade
Current Unearned Revenue
26.6124.1314.548.14.29
Upgrade
Other Current Liabilities
3.95.765.524.687.42
Upgrade
Total Current Liabilities
67.6656.2349.0433.1826.54
Upgrade
Long-Term Debt
1.051.652.27--
Upgrade
Long-Term Leases
7.559.4812.31--
Upgrade
Long-Term Unearned Revenue
16.115.1313.129.793.46
Upgrade
Other Long-Term Liabilities
11.418.9117.1814.9511.7
Upgrade
Total Liabilities
103.76101.3993.9357.9241.69
Upgrade
Common Stock
0.130.130.140.130.02
Upgrade
Additional Paid-In Capital
430.79423.39442.89423.636.49
Upgrade
Retained Earnings
-35.2-29.18-17.03-19.61-22.61
Upgrade
Comprehensive Income & Other
0.02-1.28-0.70.90.07
Upgrade
Total Common Equity
395.74393.06425.3405.04-16.03
Upgrade
Minority Interest
--0.250.34-
Upgrade
Shareholders' Equity
395.74393.06425.55405.39178.29
Upgrade
Total Liabilities & Equity
499.5494.46519.48463.31219.98
Upgrade
Total Debt
17.0214.1418.09-2.77
Upgrade
Net Cash (Debt)
260.85248.27323.06364.62162.46
Upgrade
Net Cash Growth
5.06%-23.15%-11.40%124.44%439.34%
Upgrade
Net Cash Per Share
2.001.842.334.474.98
Upgrade
Filing Date Shares Outstanding
128.1130.82135.43134.0831.24
Upgrade
Total Common Shares Outstanding
129.21130.71135.37133.7531.24
Upgrade
Working Capital
328.78335.83404.98398.55182.09
Upgrade
Book Value Per Share
3.063.013.143.03-0.51
Upgrade
Tangible Book Value
358.95353.8410.82390.16-16.78
Upgrade
Tangible Book Value Per Share
2.782.713.032.92-0.54
Upgrade
Buildings
7.767.655.55--
Upgrade
Machinery
15.3312.797.634.351.97
Upgrade
Construction In Progress
0.360.260.180.34-
Upgrade
Leasehold Improvements
3.223.623.483.021.11
Upgrade
Updated Feb 28, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q